Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver
RALEIGH, N.C., Oct. 12 /PRNewswire/ -- Campbell Alliance, the leading
management consulting firm specializing in the pharmaceutical and
biotechnology industries, today announced that Ben Bonifant, Vice President
of the firm's Business Development (BD) practice, will moderate two
workshops at t...
ImmunoVaccine Technologies Collaborates with Defence Research & Development Canada to Strengthen Canada's Ability to Deal with Biological Threats
...of IVT's DepoVax(TM) vaccine formulation to anthrax antigens to explore new methods to prevent, prepare for, and respond to biological threats.
Nagata and his research team at DRDC are leaders in developing vaccines to fight deadly microbial pathogens and we look forward to this collaboration,...
FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD
...does not work properly. This valve opens to allow food and liquids to enter the stomach and closes to keep acid and food in the stomach.
When the les
does not close as tightly as it should, or relaxes too often, it can cause stomach contents to get into the esophagus repeatedly. The stomach is bette...
Japanese Cancer Association and Debiopharm Honour Japanese Research
...rd" designed to mentor and
motivate young innovative European researchers in the field of life
sciences, and in June, the "Prix Debiopharm Valais pour les
Sciences de la
Vie" aimed at encouraging entrepreneurship in the life sciences and
technology sectors in the canton of Valais.
About Debiopharm Grou...
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
...erim basis until a successor is
appointed. A search will be undertaken to identify a successor.
Dr. Mollica stated, "We appreciate the contributions les
has made to
the progress of the company since 2004 and wish him well. Pharmacopeia will
build on its efforts in the development of pharmaceutical prod...
Pharmacopeia to Receive $5 Million Payment from GlaxoSmithKline
...llaboration model at GSK."
"The exceptional productivity of the alliance so far reflects how well
its goals fit with Pharmacopeia's strengths," said les
President and Chief Executive Officer of Pharmacopeia. "We expect the
excellent progress to continue as we focus on moving candidates t...
Pharmacopeia Announces Management Team Changes
... has facilitated the successful
transformation of Pharmacopeia into a clinical stage development company by
helping to build our broad pipeline," said les
Pharmacopeia's President and Chief Executive Officer. "While we are
saddened to see him leave his day-to-day position, we are very plea...
Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
Affymax's lead product candidate, Hematide(TM), for the treatment of
anemia. The Affymax and Takeda collaboration was recognized by the les
one of the most notable deals in the healthcare industry sector in the last
year. The 2007 Deal of Distinction Award recognizes worthy transaction...
Dane County mapping software updated, available to public
...lsen said, and property lines are updated monthly a figure the county would like to improve, but which is already much better than many systems.
Chappell contributed to this report ...
Wisconsin introduces new state IT plan
...le detail on whats going on and whats going to happen.
Mike Klein is WTNs editorial director and can be reached at firstname.lastname@example.org . les
Chappell, a staff writer for WTN, can be reached at email@example.com ....
Games that make leaders: top researchers on the rise of play in business and education
...s as good or bad, Gee said. It depends on what youre doing.
Jason Stitt is WTN's associate editor and can be reached at firstname.lastname@example.org . les
Chappell is a staff writer and can be contacted at email@example.com ...
Measuring siRNA-mediated knockdown of IL-8 mRNA
...occurs when bDNA amplifiers bind the mRNA via the LEs. Signal amplification is precisely controlled by, and is directly proportional to, the number of les
in the Probe Set, which is more reproducible than target amplification or PCR. As a result, the final luminescent readout is directly proportional to ...